Company Profile

Genfit (NASDAQ: GNFT)
5:30 PM UTC, 07/03/24
Last: $3.97 Change: +0.00 %Change: +0.00% Volume: 1,198
Detailed Quote
Open: $ 3.96   Volume: 1,198
High: $ 3.98   Yield(%) 0.00
Low: $ 3.94   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 197.54M
EPS ($) n/a   Shares Out: 49.76M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -26.74
% Price Change (last 13 weeks): 11.20
% Price Change (last 26 weeks): -1.49
% Price Change (last 52 weeks): 6.15
% Price Change (year to date): 3.12
Management Effectiveness
Return on Equity (%): -35.74
Return on Assets (%): -14.84
Return on Invested Capital (%): -13.88
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): -101.15
Operating Profit Margin (%): -127.97
Price & Volume
50-day Moving Average: $4.18
200-day Moving Average: $3.65
Avg. Daily Vol. (last 50 days): 28,062
Avg. Daily Vol. (last 200 days): 19,217
52-wk high: $6.05
52-wk low: $2.89
Bid: $3.84
Ask: $3.99
Company Information
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.
Genfit
Parc Eurasante 885, Avenue Eugène Avinée Lille Métropole
Loos HF 59120

Phone: 33.3.20.16.40.00
Fax: 33.3.20.16.40.01
http://www.genfit.com
Per Share Data
Earnings (1year) ($): -0.63
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 1.50
Cash Flow ($): -0.59
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 6.20
Price/Book (x): 2.57
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 2.94
Current Ratio (x): 2.94
LT Debt/Equity (x): 92.33
Total Debt/Equity (x): 104.08



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.